II 

Calendar No. 510 

116TH CONGRESS 

2D SESSION H. R. 3153 

[Report No. 116–248] 

IN THE SENATE OF THE UNITED STATES 

JULY 24, 2019 

Received; read twice and referred to the Committee on Commerce, Science, 

and Transportation 

AUGUST 6, 2020 

Reported by Mr. WICKER, with an amendment 

[Strike out all after the enacting clause and insert the part printed in italic] 

AN ACT 

To direct the Director of the National Science Foundation 

to support research on opioid addiction, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE; FINDINGS. 

4 (a) SHORT TITLE.—This Act may be cited as the 

5 ‘‘Expanding Findings for Federal Opioid Research and 

6 Treatment Act’’ or the ‘‘EFFORT Act’’. 

7 (b) FINDINGS.—The Congress finds that— 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 3153 RS

1 (1) research gaps currently exist in the preven2 tion and treatment of opioid addiction; 

3 (2) the National Science Foundation’s research 

4 on opioid addiction has increased understanding of 

5 the neuroscience of addiction, substance abuse inter6 vention, the role of illicit supply networks, the sec7 ondary effects on families, the use of technology to 

8 address the opioid epidemic, and options for alter9 native, non-addictive therapeutics for pain; and 

10 (3) the National Science Foundation and the 

11 National Institutes of Health have recognized that 

12 fundamental questions in basic, clinical, and 

13 translational research would benefit greatly from 

14 multidisciplinary approaches and collaboration. 

15 SEC. 2. NSF SUPPORT OF RESEARCH ON OPIOID ADDIC16 TION. 

17 The Director of the National Science Foundation, in 

18 consultation with the Director of the National Institutes 

19 of Health, shall support merit-reviewed and competitively 

20 awarded research on the science of opioid addiction. 

21 SECTION 1. SHORT TITLE; FINDINGS. 

22 (a) SHORT TITLE.—This Act may be cited as the ‘‘Ex23 panding Findings for Federal Opioid Research and Treat24 ment Act’’ or the ‘‘EFFORT Act’’. 

25 (b) FINDINGS.—Congress finds that— 


kjohnson on DSK79L0C42PROD with BILLS
3 

•HR 3153 RS

1 (1) research gaps exist in the prevention and 

2 treatment of opioid addiction; 

3 (2) the National Science Foundation’s research 

4 on opioid addiction has increased understanding of 

5 the neuroscience of addiction, substance abuse inter6 vention, the role of illicit supply networks, the sec7 ondary effects on families, the use of technology to ad8 dress the opioid epidemic, and options for alternative, 

9 non-addictive therapeutics for pain; and 

10 (3) the National Science Foundation and the Na11 tional Institutes of Health have recognized that fun12 damental questions in basic, clinical, and 

13 translational research would benefit greatly from mul14 tidisciplinary approaches and collaboration. 

15 SEC. 2. NSF SUPPORT OF RESEARCH ON OPIOID ADDIC16 TION. 

17 (a) IN GENERAL.—The Director of the National 

18 Science Foundation, in consultation with the Director of 

19 the National Institutes of Health, shall support merit-re20 viewed and competitively-awarded research on the science 

21 of opioid addiction. 

22 (b) AUTHORIZATION OF APPROPRIATIONS.—To carry 

23 out this section, there are authorized to be appropriated 

24 $10,000,000 for each of fiscal years 2020 through 2024. 


kjohnson on DSK79L0C42PROD with BILLS
Calendar No. 510 

116TH CONGRESS 

2D SESSION H. R. 3153 

[Report No. 116–248] 

AN ACT 

To direct the Director of the National Science 

tion, and for other purposes. Foundation to support research on opioid addicAUGUST 6, 2020 

Reported with an amendment 


kjohnson on DSK79L0C42PROD with BILLS